251 related articles for article (PubMed ID: 23369450)
21. Effect of curative versus palliative surgical treatment for stage III pancreatic cancer patients.
Kymionis GD; Konstadoulakis MM; Leandros E; Manouras A; Apostolou A; Alexiou D; Katsaragakis S; Androulakis G
J R Coll Surg Edinb; 1999 Aug; 44(4):231-5. PubMed ID: 10453145
[TBL] [Abstract][Full Text] [Related]
22. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
Słojewski M
Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
[TBL] [Abstract][Full Text] [Related]
23. Pancreatic resections after chemoradiotherapy for locally advanced ductal adenocarcinoma: analysis of perioperative outcome and survival.
Massucco P; Capussotti L; Magnino A; Sperti E; Gatti M; Muratore A; Sgotto E; Gabriele P; Aglietta M
Ann Surg Oncol; 2006 Sep; 13(9):1201-8. PubMed ID: 16955382
[TBL] [Abstract][Full Text] [Related]
24. [Surgical palliation for pancreatic cancer. The 25-year experience of a single reference centre].
Popiela T; Kedra B; Sierzega M; Kubisz A
Zentralbl Chir; 2002 Nov; 127(11):965-70. PubMed ID: 12476370
[TBL] [Abstract][Full Text] [Related]
25. Diagnosis and management of pancreatic cancer.
De La Cruz MS; Young AP; Ruffin MT
Am Fam Physician; 2014 Apr; 89(8):626-32. PubMed ID: 24784121
[TBL] [Abstract][Full Text] [Related]
26. Treatment of Pancreatic Adenocarcinoma in Elderly Patients over 75 Years of Age: A Retrospective Series of 129 Patients.
Oziel-Taieb S; Faure M; Gilabert M; Autret A; Turrini O; Moureau-Zabotto L; Giovannini M; Rousseau F; Raoul JL
J Gastrointest Cancer; 2016 Mar; 47(1):15-9. PubMed ID: 26545612
[TBL] [Abstract][Full Text] [Related]
27. Prognostic factors in nonresectable pancreatic adenocarcinoma: a rationale to design therapeutic trials.
Cubiella J; Castells A; Fondevila C; Sans M; Sabater L; Navarro S; Fernández-Cruz L
Am J Gastroenterol; 1999 May; 94(5):1271-8. PubMed ID: 10235206
[TBL] [Abstract][Full Text] [Related]
28. Effect of different treatment methods on survival in patients with pancreatic cancer.
Brasiūniene B; Juozaityte E; Inciūra A; Brasiūnas V; Barauskas G
Rocz Akad Med Bialymst; 2003; 48():66-9. PubMed ID: 14737944
[TBL] [Abstract][Full Text] [Related]
29. [Effort to radically cure stage III and IV esophageal carcinoma with simultaneous radiotherapy and chemotherapy in standard clinical practice].
Farzad M; De Luca MC; Rubino G; Pirtoli L; Pepi F; Sebaste L; Ponticelli P; Atzeni G; Maranzano E; Silvano G
Radiol Med; 2001; 102(1-2):72-7. PubMed ID: 11677442
[TBL] [Abstract][Full Text] [Related]
30. Defining optimum treatment of patients with pancreatic adenocarcinoma using regret-based decision curve analysis.
Hernandez JM; Tsalatsanis A; Humphries LA; Miladinovic B; Djulbegovic B; Velanovich V
Ann Surg; 2014 Jun; 259(6):1208-14. PubMed ID: 24169177
[TBL] [Abstract][Full Text] [Related]
31. [Pancreatic carcinoma].
Böhmig M; Rosewicz S
Z Gastroenterol; 2004 Mar; 42(3):261-8. PubMed ID: 15022114
[TBL] [Abstract][Full Text] [Related]
32. Multidisciplinary management of locally advanced pancreatic ductal adenocarcinoma.
Alemi F; Alseidi A; Scott Helton W; Rocha FG
Curr Probl Surg; 2015 Sep; 52(9):362-98. PubMed ID: 26363649
[No Abstract] [Full Text] [Related]
33. Carcinoma of the ampulla of Vater: results of surgical treatment of a single center.
Memon MA; Shiwani MH; Anwer S
Hepatogastroenterology; 2004; 51(59):1275-7. PubMed ID: 15362731
[TBL] [Abstract][Full Text] [Related]
34. A twenty-year experience with adenocarcinoma of the anal canal.
Chang GJ; Gonzalez RJ; Skibber JM; Eng C; Das P; Rodriguez-Bigas MA
Dis Colon Rectum; 2009 Aug; 52(8):1375-80. PubMed ID: 19617747
[TBL] [Abstract][Full Text] [Related]
35. Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors.
Cleary SP; Gryfe R; Guindi M; Greig P; Smith L; Mackenzie R; Strasberg S; Hanna S; Taylor B; Langer B; Gallinger S
J Am Coll Surg; 2004 May; 198(5):722-31. PubMed ID: 15110805
[TBL] [Abstract][Full Text] [Related]
36. The prognostic effect of clinical staging in pancreatic adenocarcinoma.
Morganti AG; Brizi MG; Macchia G; Sallustio G; Costamagna G; Alfieri S; Mattiucci GC; Valentini V; Natale L; Deodato F; Mutignani M; Doglietto GB; Cellini N
Ann Surg Oncol; 2005 Feb; 12(2):145-51. PubMed ID: 15827795
[TBL] [Abstract][Full Text] [Related]
37. Adenocarcinoma of the small bowel: presentation, prognostic factors, and outcome of 217 patients.
Dabaja BS; Suki D; Pro B; Bonnen M; Ajani J
Cancer; 2004 Aug; 101(3):518-26. PubMed ID: 15274064
[TBL] [Abstract][Full Text] [Related]
38. [Expression of dihydropyrimidine dehydrogenase negatively correlated with the prognosis of pancreatic ductal adenocarcinoma].
Fang Y; Ji Y; Lou WH
Zhonghua Wai Ke Za Zhi; 2011 Apr; 49(4):330-4. PubMed ID: 21612699
[TBL] [Abstract][Full Text] [Related]
39. Serum C-reactive protein concentration and the prognosis of ductal adenocarcinoma of the head of pancreas.
Pine JK; Fusai KG; Young R; Sharma D; Davidson BR; Menon KV; Rahman SH
Eur J Surg Oncol; 2009 Jun; 35(6):605-10. PubMed ID: 19128923
[TBL] [Abstract][Full Text] [Related]
40. CD74 is a novel prognostic factor for patients with pancreatic cancer receiving multimodal therapy.
Nagata S; Jin YF; Yoshizato K; Tomoeda M; Song M; Iizuka N; Kitamura M; Takahashi H; Eguchi H; Ohigashi H; Ishikawa O; Tomita Y
Ann Surg Oncol; 2009 Sep; 16(9):2531-8. PubMed ID: 19499276
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
